Analysis of additive effects of rivaroxaban added to plasma of patients treated with vitamin-K antagonists

被引：0
|
作者：
Harenberg, J. [1 ]
Giese, C. [1 ]
Marx, S. [1 ]
Weiss, C. [2 ]
Kraemer, R. [3 ]
机构：
[1] Univ Med Mannheim, Mannheim, Germany
[2] Fac Med Mannheim, Dept Biometry & Biomed Stat, Mannheim, Germany
[3] Heidelberg Univ, Inst Inorgan Chem, D-69115 Heidelberg, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-TU-179
引用
收藏
页码：365 / 365
页数：1
相关论文
共 50 条
  • [1] VITAMIN-K ANTAGONISTS
    ACAR, J
    DEWILDE, J
    SAMAMA, M
    REVUE DU PRATICIEN, 1977, 27 (57): : 3977 - &
  • [2] Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
    Martinelli, Ida
    Abbattista, Maria
    Bucciarelli, Paolo
    Tripodi, Armando
    Artoni, Andrea
    Gianniello, Francesca
    Novembrino, Cristina
    Peyvandi, Flora
    HAEMATOLOGICA, 2018, 103 (07) : E315 - E317
  • [3] VITAMIN-K METABOLISM IN A CASE OF VITAMIN-K ANTAGONISTS RESISTANCE
    KEREVEUR, A
    LECLERCQ, M
    TROSSAERT, M
    DUPEYRON, JP
    PARENT, F
    HORELLOU, MH
    CONARD, J
    BACHMANN, F
    SAMAMA, MM
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1111 - 1111
  • [4] Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists
    De Crem, Nico
    Peerlinck, Kathelijne
    Vanassche, Thomas
    Vanheule, Kristine
    Debaveye, Barbara
    Middeldorp, Saskia
    Verhamme, Peter
    Peetermans, Marijke
    THROMBOSIS RESEARCH, 2015, 136 (04) : 749 - 753
  • [5] VISCOELASTIC PROPERTIES OF PLASMA FIBRIN CLOTS ARE SIMILAR IN PATIENTS ON RIVAROXABAN AND VITAMIN K ANTAGONISTS
    Kopytek, M.
    Zabczyk, M.
    Natorska, J.
    Siudut, J.
    Malinowski, K. P.
    Ptaszek, P.
    Glajcar, A.
    Goralczyk, T.
    Undas, A.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2019, 70 (01): : 79 - 85
  • [6] Switching to Direct Anticoagulation or Continued Vitamin-K Antagonists in Frail Patients With Atrial Fibrillation in Whom Vitamin-K Antagonists Are Tolerated?
    Wallentin, Lars
    Giugliano, Robert P.
    CIRCULATION, 2024, 149 (04) : 290 - 292
  • [7] Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists
    Di Nisio, Marcello
    Ageno, Walter
    Rutjes, Anne W. S.
    Pap, Akos F.
    Bueller, Harry R.
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 424 - 432
  • [8] MODE OF ACTION OF VITAMIN-K ANTAGONISTS
    BELL, RG
    CALDWELL, P
    LALIBERTE, R
    REN, P
    FEDERATION PROCEEDINGS, 1973, 32 (MAR) : 944 - +
  • [9] DETERMINATION OF PLASMA VITAMIN-K IN PATIENTS WITH HEPATOMA
    HONJO, K
    UEHARA, S
    HIRANO, F
    SAKAI, N
    GOTO, K
    HIRAYAMA, A
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 368 - 368
  • [10] Phlebothrombosis - Use of vitamin-K antagonists
    Schwieder, G
    INTERNIST, 1997, 38 (03): : 261 - 261
12345